bf/NYSE:DNA_icon.jpeg

NYSE:DNA

Ginkgo Bioworks Holdings, Inc.

  • Stock

USD

Last Close

0.46

14/06 17:50

Market Cap

2.73B

Beta: 0.89

Volume Today

26.83M

Avg: 18.92M

PE Ratio

−2.78

PFCF: −6.38

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, ...Show More

Earnings per Share (Estimate*)

-0.4-0.3-0.2-0.12001-03-312020-09-302021-09-202022-05-162023-03-012023-11-08

Revenue (Estimate*)

50M100M150M2001-03-312020-09-302021-09-202022-05-162023-03-012023-11-08

*Estimate based on analyst consensus